Moreover, studies currently ongoing show that myo-Ins increases FSH receptor and aromatase synthesis in granulosa cells, probably through an FSH-independent mechanism of action, as myo-Ins raises the transcription of aromatase also in breast cancer cells without any previous FSH administration [96]. The gene discussed is BRD2; the disease is breast cancer.